The present invention relates to methods of diagnosis, therapy, and screening of new therapeutic compounds in the field of osteogenesis, based on the differential expression observed for the genes of the invention, represented by SEQ ID No 2, 7, 22, 25, 33, 35, 37, 38, 42, 47, 64, 69 or 77, 82, 97, 100, 108, 110, 112, 113, 117, 122, 139, 151, 158, 160, 172, 182, 184, 187, 188, 194.

 
Web www.patentalert.com

< Aldehyde reductase

< Ceramide kinase and uses thereof

> Simple process for obtaining beta-aescin from indian horse chesnut (aesculus indica)

> Nucleic acid molecules and other molecules associated with plants

~ 00237